Mild Infection

null

null

null

null

null

null

Mild Infection

15  articles in this collection
Written by Mathias Castonguay, Camille Blouin, Noémie Desgagnés, Audrey Mathieu, 

The Use of Corticosteroids in Adrenal Insufficiency

The World Health Organization has recently advised against corticosteroids use in COVID-19 patients, unless indicated for another reason, as in adrenal insufficiency (AI). Indeed, both patients with primary or secondary AI are at higher risk of developing infections, precipitating an adrenal crisis. No specific protocol has been studied for AI patients in the context of […]

Written by
06/05/2020

Postpartum Care and Breastfeeding

Delayed umbilical cord clamping does not seem to increase pathogens transmission. Leaving vernix caseosa in place 24h after birth can be considered due to the presence of antimicrobial peptides. The majority of neonatal infections are caused by the environment and droplet transmission from the mother and other relatives.  Physical separation at birth can be considered […]

Written by
03/28/2020

Management of autoimmune bullous diseases

Recommendations for AIBD patients undergoing immunosuppressive therapy during the pandemic :  Immunomodulatory therapy should be maintained when necessary since unjustified withdrawal could lead to uncontrolled AIBD activity.  Adhere to standard precautions including social distancing and hand washing.  What if AIBD patients are SARS-CoV-2 infected ?  Evaluate the risk for each patient.  May be stopped during […]

Written by
04/30/2020

Recommendations for Antenatal Care

Symptomatic and asymptomatic pregnant women should be tested if they have travelled to an affected country or have been in close contact with a person who tested positive for the disease within the last 14 days.  The number of visits to the hospital needs to be reduced to the minimum. It is suggested to try […]

Written by and
04/09/2020

Treatment Options for Pregnant Women

Confirmed cases should be treated in a negative pressure isolation room when available. Critically ill patients should be placed in left lateral decubitus. Treatment options include oxygen therapy, hydration, and empirical antibiotic therapy. The use of antiretroviral therapy and chloroquine is under investigation. Target saturation is ≥ 95%.   Is hydroxychloroquine safe in pregnancy? Some […]

Written by
04/15/2020

Acral Lesions: What We Know

1. Initial reports of acute acro-ischemic lesions in children were published by Mazzotta F. and Trocolli T. 2. Terms used include acral lesions, acro-ischemic lesions, perniosis, pernio or chilblain (also -like or pseudo-). 3. Acral lesions are often reported in children and young adults. Median age: 19,9 years old (Fernandez-Nieto D. et al.), 14 years […]

Written by
05/05/2020

Antimalarials Need Further Studies

Few papers suggested that viral replication in vitro was diminished by chloroquine, but those were only laboratory studies. It has not been supported by animal studies; Antimalarial drugs such as chloroquine and its derivatives are associated with significant adverse effects; Particularly in times of restricted supplies, unjustified and/or overuse can cause drug shortages for those […]

Written by
05/04/2020

Are NSAIDs Safe with Children?

Fever in pediatric patients is usually managed using antipyretic medication like acetaminophen and ibuprofen; A review of case-control studies² proposed that NSAIDs could increase the risks of complications in cases of respiratory disease. The hypothesis lies in the inhibiting effect on cyclo-oxygenase, which diminishes white cells recruitment and making harder for the inflammation to resolve; No […]

Written by
05/04/2020

Symptomatology in Neonates

In 33 neonates at risk or with COVID-19, four of them presented with shortness of breath, thus being the most common symptom; Two positive neonates experienced lethargy and fever and one had vomiting; All of the three positive patients developed pneumonia as shown on their chest x-ray; One patient who needed 11 days of NICU […]

Written by
04/22/2020

Considerations in the Management of Diabetes in the Pandemic Context

Diabetes is an important risk factor for poorer outcomes in COVID-19. Mechanistic hypotheses include the effect of acute and chronic hyperglycemia on angiotensin-converting-enzyme-2 receptor, impaired immune response and confounding population characteristics such as age and cardiovascular comorbidities. Prevention: Patients at risk of metabolic disease who have contracted the infection should be monitored to prevent new […]

Written by
05/04/2020

Presentation and Outcomes in Pregnant Women

Clinical manifestations : Clinical manifestations in pregnant women were comparable to those seen in infected non-pregnant adults.  Initial normal body temperature was seen more commonly in pregnant women, thus rendering early detection of the virus more difficult in this population.  It has not been shown that pregnancy is a risk factor for more severe infection. […]

Written by and
04/05/2020

Immunosuppressants Use in Dermatology during the Outbreak

There is currently no data about the benefits or the risks of stopping immunomodulators/immunosuppressants during the COVID-19 outbreak.  Pre-coronavirus pivotal trials for psoriasis show that patients under biologic therapies had respiratory infection rates similar to placebo.  Price et al recommend:  Consider stopping classic immunosuppressants and rituximab  when viral symptoms present, especially with known or potential […]

Written by
04/10/2020

Rationale of Favipiravir Against New Pandemic

Before COVID-19: Favipiravir is approved in Japan and China for treating severe influenza virus, as well as a promising prophylaxis and treatment of Ebola virus and treatment of Fever with Thrombocytopenia Syndrome.1   It was shown to be safe in several human clinical trials for influenza.1  It is renowned for its broad anti-RNA virus action1, and […]

Written by
04/12/2020

Kidney Function and Mortality

AKI (acute kidney injury) is independently strongly associated with increased mortality and morbidity and is dependent on its severity (Stage 1 HR = 3.51, Stage 2 HR = 6.24, Stage 3 HR = 9.81)1 CKD (chronic kidney disease) is associated with enhanced risk of severe COVID-19 infection (OR 3.03)2 and a greater in-hospital mortality (HR […]

Written by
04/01/2020

Lymphopenia as a Classification and Prediction Tool

The LYM% (blood lymphocyte percentage) can be used as a reliable indicator to classify the infection as moderate, severe and critical independently of any other auxiliary indicators. TML (Time-LYM%-model) is a tool of classification and prognosis prediction. TML-1 is defined as the LYM% at day 10-12 after symptom onset and TML-2 is the LYM% at […]

Written by
04/01/2020